Gruppo Italiano Mammella (GIM)

3 clinical trials · Sponsor

Record	Firm	Date
Fulvestrant With or Without Lapatinib and/or Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer That Progressed After Previous Aromatase Inhibitor Therapy (NCT00688194)	Gruppo Italiano Mammella (GIM)	2008-05-01
Study of Anastrozole, Letrozole, or Exemestane With or Without Tamoxifen in Treating Postmenopausal Women With Hormone-Responsive Breast Cancer That Has Been Completely Removed By Surgery (NCT00541086)	Gruppo Italiano Mammella (GIM)	2007-03-01
Triptorelin in Preventing Early Menopause in Premenopausal Women Who Are Receiving Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery (NCT00311636)	Gruppo Italiano Mammella (GIM)	2003-09-01

Every clearance here is in the API, with alerts when new ones post.